Interferon antagonism by SARS-CoV-2: a functional study using reverse genetics
暂无分享,去创建一个
M. Müller | D. Muth | C. Drosten | D. Niemeyer | Simon Schroeder | C. Goffinet | F. Pott | T. Veith | A. Richter | S. Schroeder | Talitha Veith
[1] S. Chanda,et al. SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling , 2020, Proceedings of the National Academy of Sciences.
[2] Christian Drosten,et al. Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention , 2020 .
[3] Sebastian Maurer-Stroh,et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study , 2020, The Lancet.
[4] L. Ren,et al. Activation and evasion of type I interferon responses by SARS-CoV-2 , 2020, Nature Communications.
[5] M. Alexander,et al. Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention , 2020, bioRxiv.
[6] O. Tsang,et al. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study , 2020, The Lancet Microbe.
[7] P. Vollmar,et al. Virological assessment of hospitalized patients with COVID-2019 , 2020, Nature.
[8] G. Herrler,et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.
[9] A. M. Leontovich,et al. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.
[10] B. Graham,et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.
[11] P. Niu,et al. Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China , 2020, Cell Host & Microbe.
[12] P. Vollmar,et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany , 2020, The New England journal of medicine.
[13] G. Gao,et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 , 2020, The New England journal of medicine.
[14] K. To,et al. SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists , 2020, Emerging microbes & infections.
[15] A. Pfeifer,et al. Attenuation of replication by a 29 nucleotide deletion in SARS-coronavirus acquired during the early stages of human-to-human transmission , 2018, Scientific Reports.
[16] Christian Drosten,et al. The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species , 2018, PLoS pathogens.
[17] V. Thiel,et al. To sense or not to sense viral RNA — essentials of coronavirus innate immune evasion , 2014, Current Opinion in Microbiology.
[18] F. Weber,et al. Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist , 2013, Journal of Virology.
[19] Markus Eickmann,et al. Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus , 2013, Journal of Virology.
[20] R. Baric,et al. SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon , 2012, Current Opinion in Virology.
[21] P. Nelson,et al. Influenza and SARS-Coronavirus Activating Proteases TMPRSS2 and HAT Are Expressed at Multiple Sites in Human Respiratory and Gastrointestinal Tracts , 2012, PloS one.
[22] K. Schughart,et al. TMPRSS2 and TMPRSS4 Facilitate Trypsin-Independent Spread of Influenza Virus in Caco-2 Cells , 2010, Journal of Virology.
[23] H. Garner,et al. Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection , 2010, PloS one.
[24] F. Weber,et al. Interferon and cytokine responses to SARS-coronavirus infection , 2008, Cytokine & Growth Factor Reviews.
[25] Krishna Shankara Narayanan,et al. Severe Acute Respiratory Syndrome Coronavirus nsp1 Suppresses Host Gene Expression, Including That of Type I Interferon, in Infected Cells , 2008, Journal of Virology.
[26] Zhongbin Chen,et al. Regulation of IRF-3-dependent Innate Immunity by the Papain-like Protease Domain of the Severe Acute Respiratory Syndrome Coronavirus , 2007, Journal of Biological Chemistry.
[27] M. Diamond,et al. Cell-Specific IRF-3 Responses Protect against West Nile Virus Infection by Interferon-Dependent and -Independent Mechanisms , 2007, PLoS pathogens.
[28] Ralph S. Baric,et al. Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane , 2007, Journal of Virology.
[29] J. Casanova,et al. Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling , 2007, Journal of Virology.
[30] P. Palese,et al. Severe Acute Respiratory Syndrome Coronavirus Open Reading Frame (ORF) 3b, ORF 6, and Nucleocapsid Proteins Function as Interferon Antagonists , 2006, Journal of Virology.
[31] A. Takaoka,et al. Interferon signalling network in innate defence , 2006, Cellular microbiology.
[32] Andreas Pichlmair,et al. Inhibition of Beta Interferon Induction by Severe Acute Respiratory Syndrome Coronavirus Suggests a Two-Step Model for Activation of Interferon Regulatory Factor 3 , 2005, Journal of Virology.
[33] Pegylated Interferon-alpha Protects Type 1 Pneumocytes Against SARS Coronavirus Infection in Macaques , 2004 .
[34] Ton de Jong,et al. Pegylated interferon-α protects type 1 pneumocytes against SARS coronavirus infection in macaques , 2004, Nature Medicine.
[35] M J Morgan,et al. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. , 1979, The Journal of general virology.